ANP’s short half-life (derived from its higher affinity for NPR-C) precludes its utilization in routine practice while BNP’s stability makes it a desirable biomarker in HF diagnosis and prognosis (Table 2). The gene discussed is NPPA; the disease is hydrops fetalis.